Clinical Lipidology: A Companion to Braunwald's Heart Disease E-Book , livre ebook

icon

1110

pages

icon

English

icon

Ebooks

2008

Écrit par

Publié par

icon jeton

Vous pourrez modifier la taille du texte de cet ouvrage

Lire un extrait
Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
icon

1110

pages

icon

English

icon

Ebooks

2008

icon jeton

Vous pourrez modifier la taille du texte de cet ouvrage

Lire un extrait
Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Dr. Ballantyne—one of the foremost lipid experts in the world and recruited by Dr. Braunwald’s Heart Disease editorial team—together with a stellar cast of contributors provides all of the scientific and clinical information you need to effectively manage every aspect of dyslipidemia. From basic science to pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options, this new title in the Braunwald’s Heart Disease family offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style.

• Features the expertise of one of the foremost experts in the field, ensuring you get authoritative guidance with the most definitive knowledge available.

• Contains extensive clinically relevant information covering risk assessment, therapy, special patient populations, and experimental therapies, including targeting HDL to help you effectively manage any challenges you face.

• Uses treatment algorithms for easy access to key content.

• Presents current practice guidelines that assist in the decision-making process.


Voir icon arrow

Publié par

Date de parution

18 décembre 2008

Nombre de lectures

3

EAN13

9781437711233

Langue

English

Poids de l'ouvrage

6 Mo

Plasma Enzyme Copyright Philadelphie Tool (groupe) Inflammation IDL Triglycéride Mutation Electronic Oméga-3 Lipoprotéine de très basse densité Protéine C réactive Récipient Assay Fénofibrate Lésion Niacin Aspirin Feed Father Cholestérol Clofibrate Hypertension artérielle Cardiology Cholestyramine Bioinformatics Cholesterol Major depressive disorder Diet Food Fatty acid Lipid Mass Magnetic resonance imaging Mechanics Omega-3 fatty acid Positron emission tomography Phospholipid Spectroscopy Data storage device Tool Transient ischemic attack Diabetes mellitus Blood vessel Philadelphia X-ray computed tomography Nut Vitamin E Metabolic syndrome Insulin resistance Abdominal obesity Genomics Proteomics Obesity Heart disease Angioplasty Electrocardiography Hypertension Atherosclerosis Lipoprotein Medical ultrasonography Diabetes mellitus type 2 Paste Organ transplantation Transplant Statin Physical exercise General practitioner Internal medicine Cannabinoid Risk assessment Heparin Heart failure Lipodystrophy Health care Renal failure C-reactive protein Aerobic exercise Lesion Weight loss Angiography Mediterranean diet Protein isoform Physician assistant Very low-density lipoprotein Cardiovascular disease Hypercholesterolemia Dyslipidemia Stroke Atorvastatin Simvastatin Fluvastatin Rosuvastatin Pravastatin Diet (nutrition) Hypertriglyceridemia Combined hyperlipidemia Protease inhibitor (pharmacology) Bile acid sequestrant Acute kidney injury Chronic kidney disease Gemfibrozil Ezetimibe Fatty liver Apheresis Fish oil Functional food Sterol Protein S Guideline End stage renal disease Kidney transplantation Apolipoprotein Hyperlipidemia Sedentary lifestyle Phytosterol Acute coronary syndrome Bile acid Apolipoprotein B Apolipoprotein C2 Spectrum analysis Cholestane Cholesterol absorption inhibitor Familial hypercholesterolemia Lipoprotein(a) Apolipoprotein A1 Colesevelam Colestipol Therapy 1-alkyl-2-acetylglycerophosphocholine esterase Fatty-acid synthase Vertical Auto Profile Photocopier Myocardial infarction VIH Derecho de autor Ácido graso omega 3 Dieta thérapies

Clinical Lipidology
A Companion to Braunwald’s Heart Disease
First Edition

Christie M. Ballantyne, M.D.
Professor of Medicine, Chief, Section of Atherosclerosis and Vascular Medicine, Baylor College of Medicine, Houston, Texas
SAUNDERS
Copyright
SAUNDERS ELSEVIER
1600 John F. Kennedy Blvd.
Ste 1800
Philadelphia, PA 19103-2899
CLINICAL LIPIDOLOGY: A COMPANION TO BRAUNWALD’S
HEART DISEASE
ISBN: 978-1-4160-5469-6
Copyright © 2009 by Saunders, an imprint of Elsevier Inc.
All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may be sought directly from Elsevier’s Rights Department: phone: (+1) 215 239 3804 (US) or (+44) 1865 843830 (UK); fax: (+44) 1865 853333; e-mail: healthpermissions@elsevier.com . You may also complete your request on-line via the Elsevier website at http://www.elsevier.com/permissions .


Notice
Knowledge and best practice in this field are constantly changing. As new research and experience broaden our knowledge, changes in practice, treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be administered, to verify the recommended dose or formula, the method and duration of administration, and contraindications. It is the responsibility of the practitioner, relying on their own experience and knowledge of the patient, to make diagnoses, to determine dosages and the best treatment for each individual patient, and to take all appropriate safety precautions. To the fullest extent of the law, neither the Publisher nor the Authors assume any liability for any injury and/or damage to persons or property arising out of or related to any use of the material contained in this book.
The Publisher
Library of Congress Cataloging-in-Publication Data
Clinical lipidology : a companion to Braunwald’s heart disease / [edited by] Christie M. Ballantyne. — 1st ed.
p.; cm.
ISBN 978-1-4160-5469-6
1. Lipids. 2. Lipoproteins. 3. Heart—Diseases. I. Ballantyne, Christie M. II. Braunwald’s heart disease.
[DNLM: 1. Lipoproteins—metabolism. 2. Cardiovascular Diseases—complications. 3. Dyslipidemias. 4. Lipid Metabolism. QY 465 C641 2009]
QP751.C55 2009
612.3’97—dc22
Executive Publisher: Natasha Andjelkovic
Editorial Assistant: Isabel Trudeau
Senior Project Manager: David Saltzberg
Design Direction: Steve Stave
Cover artwork provided by Peter Libby and Steven Lee
Printed in China
Last digit is the print number: 9 8 7 6 5 4 3 2 1
Acknowledgments
I would like to thank my family for their support during the writing of this book, since it meant time away from them: My wife, Yasmine, and my daughers, Leyla, Christina, and Katina.
I would also like to thank the individuals who inspired me to pursue academic preventive cardiology: Donald Seldin, who inspired me to teach; Jim Willerson, who was a role model for hard work and dedication to patient care; Art Beaudet, for his rigorous approach to the scientific method and critical thinking; and Tony Gotto, who was a role model as a clinician–scientist–educator–father–administrator.
I would also like to thank Kerrie Jara for her help in preparing this book.
Contributing Authors

Gerd Assmann, M.D., Institut for Klinische Chemie und Laboratoriumsmedizin, Albert-Schweitzer, Munster, Germany

Deborah Bagshaw, The Pennsylvania State University, University Park, Pennsylvania

Ashok Balasubramanyam, M.D., Professor of Medicine, Baylor College of Medicine, Houston, Texas

Christie M. Ballantyne, M.D., Professor of Medicine, Chief, Section of Atherosclerosis and Vascular Medicine, Baylor College of Medicine, Houston, Texas

Philip Barter, M.D., Ph.D., FRACP, The Heart Research Institute, Sydney, Australia

Harold Bays, M.D., FACP, Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky

Roger S. Blumenthal, M.D., FACC, Professor of Medicine, Director, The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland

H. Bryan Brewer, Jr., M.D., Director, Washington Cardiovascular Associates; Senior Research Consultant, Lipoprotein and Atherosclerosis Research, Cardiovascular Research Institute, MedStar Research Institute, Washington, D.C.

B. Greg Brown, M.D., Ph.D., University of Washington, Department of Medicine, Seattle, Washington

John D. Brunzell, M.D., Professor Emeritus, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition; Clinical Director, Northwest Lipid Metabolism and Diabetes Research Laboratories; University of Washington, Seattle, Washington

Catherine Y. Campbell, M.D., Johns Hopkins Hospital, Baltimore, Maryland

Paul L. Canner, Ph.D., Maryland Medical Research Institute, Baltimore, Maryland

Lars A. Carlson, M.D., Ph.D., FRCP Edin, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden

A.L. Catapano, Professor of Pharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy

Tina J. Chahil, M.D., Columbia University College of Physicians and Surgeons, Department of Medicine, Division of Preventive Medicine and Nutrition, New York, New York

Timothy S. Church, M.D., MPH, Ph.D., Pennington Biomedical Research Center, Baton Rouge, Louisiana

David E. Cohen, M.D., Ph.D., Director of Hepatology, Division of Gastroenterology Brigham and Women’s Hospital, Harvard Medical School Director, Harvard-MIT Division of Health Sciences and Technology; Associate Professor of Medicine and Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts

Michael H. Davidson, M.D., FACC, The University of Chicago Pritzker School of Medicine, Chicago, Illinois

Prakash C. Deedwania, M.D., FAHA, FACP, FACC, Veterans Administration Central California Healthcare System, University of California Fresno, Fresno, California

Jean-Pierre Després, Ph.D., FAHA, Centre de recherche de l’Hôpital Laval, Pennsylvaniavillon Marguerite-D’Youville, Québec, Canada

Sridevi Devaraj, Ph.D., DABCC, University of California Davis Medical Center, Sacramento, California

Patrick J. Devine, M.D., Cardiology Service, Walter Reed Army Medical Center Washington, D.C.

Zahi A. Fayad, Ph.D., Mount Sinai School of Medicine, New York, New York

Sergio Fazio, M.D., Ph.D., Vanderbilt University Medical Center, Nashville, Tennessee

Bengt Fellstrøm, M.D., Ph.D., Professor of Nephrology, Department of Medical Sciences, Nephrology Unit, University Hospital, Uppsala, Sweden

Peter Ganz, M.D., University of California, San Francisco; San Francisco General Hospital, San Francisco, California

Henry N. Ginsberg, M.D., College of Physicians and Surgeons of Columbia University, Irving Institute for Clinical and Translational Research, New York, New York

Anne Carol Goldberg, M.D., FACP, FAHA, Washington University School of Medicine, St. Louis, Missouri

Antonio M. Gotto, Jr., M.D., Dphil, Weill Cornell Medical College, New York, New York

John R. Guyton, M.D., FAHA, Duke University Medical Center, Durham, North Carolina

William S. Harris, Ph.D., Sanford Research/USD and Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota

Hallvard Holdaas, M.D., Ph.D., National Hospital, Oslo, Norway

Ron C. Hoogeveen, Ph.D., Baylor College of Medicine, Houston, Texas

Terry A. Jacobson, M.D., FACP, FAHA, Emory University School of Medicine, Atlanta, Georgia

Alan G. Jardine, BSc, M.D., FRCP, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom

David J.A. Jenkins, M.D., Ph.D., Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Ishwarlal Jialal, M.D., Ph.D., University of California Davis Medical Center, Sacramento California

Peter H. Jones, M.D., The Methodist Hospital, Houston, Texas

Andrea R. Josse, Bkin, MSc, Ivor Wynne Centre, Department of Kinesiology, McMaster University, Ontario, Canada

Cyril W.C. Kendall, Ph.D., Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Jon A. Kobashigawa, M.D., University of California at Los Angeles, Los Angeles, California

Marlys L. Koschinsky, B.Sc., Ph.D., Queen’s University, Kingston, Ontario, Canada

Penny M. Kris-Etherton, Ph.D., RD, The Pennsylvania State University, Department of Nutritional Sciences, University Park, Pennsylvania

Salila Kurra, M.D., Columbia University College of Physicians and Surgeons, New York, New York

Carl J. Lavie, M.D., Ochsner Health System, New Orleans, Louisiana

Ngoc-Anh Le, Ph.D., Emory University School of Medicine and Atlanta Veterans Affairs Medical Center, Decatur, Georgia

Peter Libby, M.D., Mallinckrodt Professor of Medicine, Harvard Medical School, Chief, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts

MacRae F. Linton, M.D., Vanderbilt University Medical Center, Nashville, Tennessee

Santica M. Marcovina, Ph.D., ScD, Northwest Lipid Metabolism and Diabetes Research Laboratories, Department of Medicine, Unive

Voir icon more
Alternate Text